Cyril Amarchand Mangaldas (CAM) advised Tatvartha Health Private Limited (Traya) and its Promoters on Series B CCPS investment by Xponentia Opportunities Fund II for a stake of 6.68% in Traya for a value amounting to approximately INR 75 crores).
The transaction team was led by Dhruv Singhal, Partner; with support from Aparna Menon, Senior Associate; Hina Tolani, Associate; Shivangini Singh, Associate; Bhavya Arya, Associate; and Rushil Mehta, Associate. Other parties to the transaction are: Fireside Ventures Investment Fund – II; Whiteboard Capital Fund – I; and Beacon Trusteeship Limited- Kae Capital Fund III (acted as existing investors)
The transaction documents was signed on 27th March, 2024 and closing was done 28th March, 2024.
 (850 x 600 px) (39)_20241121094035_original_image_43.webp)
 (850 x 600 px) (36)_20241121064948_original_image_30.webp)
_20241121060428_original_image_48.webp)